SpaceX IPO: Is This Space and AI Stock Really Only Worth $780 Billion?

Morningstar says SpaceX may be worth about $780 billion, less than half of the reported $1.77 trillion IPO valuation target, and recommends investors wait for a post-IPO correction. The article highlights SpaceX's claimed $28.5 trillion TAM, but notes that $26.5 trillion of that is tied to AI, an area Morningstar views skeptically. The piece is largely a valuation warning rather than a business deterioration story, so the near-term market impact is likely limited.

Analysis

The immediate winner from a discounted SpaceX IPO is not the issuer but the public-market comparables and downstream beneficiaries of a more realistic private-market reset. If the deal prices on a stretched AI narrative and then reprices lower post-lockup, it will validate a broader de-rating of late-stage private AI assets and make public investors more selective on “AI adjacency” claims. That should modestly help names with tangible capex economics — especially NVDA on real infrastructure demand and NDAQ as a cleaner venue for listing/valuation discovery — while pressuring speculative growth proxies that depend on infinite-duration multiple expansion.

Morningstar’s pushback is also a signal that the market may be over-assigning value to optionality embedded in the AI segment versus the cash-generative launch/connectivity businesses. The second-order risk is that any near-term IPO pop could create a false read-through for the rest of the venture complex; if SpaceX trades down after the first few weeks, it will likely compress fundraising terms for frontier AI/space startups over the next 2-3 quarters. That matters for secondary supply, tender pricing, and late-stage crossover appetite more than for fundamentals in the core operating businesses.

The key catalyst window is the first 30-90 days after listing, when narrative support is strongest but financial disclosures begin to matter. If growth in the AI bucket fails to show a credible path to monetization by the first earnings cycle, the stock can quickly shift from “scarcity premium” to “hard-to-underwrite conglomerate discount.” Conversely, a successful post-IPO stabilize-and-scale would signal that the market is still willing to fund moonshot AI capex, but that outcome is more likely to benefit the financing ecosystem than justify the headline valuation.

Key Decisions for Investors

• Avoid chasing the IPO in the first 2-4 weeks; wait for the first post-listing earnings/lockup window before considering exposure. Risk/reward is poor if the stock prices on narrative rather than monetization evidence.
• Long NVDA vs short a basket of speculative AI narrative names over the next 1-3 months. If SpaceX reprices lower, real compute infrastructure should outperform story-stock exposure as capital shifts toward proven picks-and-shovels.
• Buy NDAQ on any weakness tied to IPO-market skepticism. A marquee listing that is controversial but liquid can increase venue activity and secondary trading volumes, while valuation resets elsewhere tend to drive more listing interest.
• Short MORN on strength if the market overinterprets the call as a durable edge in IPO timing. The trade works only if the stock re-rates lower after launch; stop if SpaceX prices below target or trades materially above it for multiple weeks.
• For venture/late-stage crossover books, reduce exposure to AI-pre-revenue secondaries over the next 1-2 quarters. Use SpaceX as a benchmark to renegotiate marks and avoid paying up for optionality without clear revenue conversion.